| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 18.05.
| Biosante Pharmaceuticals: The Losing Streak Continues | | 37 | SmarTrend |
| 17.05.
| Recent 52-Week Low Surpassed in Shares of Biosante Pharmaceuticals | | 14 | SmarTrend |
| 10.05.
| Possible Bullish Inside Day Candle Pattern Detected for Biosante Pharmaceuticals | | 7 | SmarTrend |
| 09.05.
| Hot Stock: Biosante Pharmaceuticals, Shares Drop 11.6% | | 19 | SmarTrend |
| 09.05.
| Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Biosante Pharmaceuticals, Inc. for Securities Fraud | | 50 | Business Wire |
| Shareholder Rights Law Firm Johnson
& Weaver, LLP announces it is investigating whether certain
officers and directors of Biosante Pharmaceuticals, Inc. (Nasdaq: BPAX)...
Mehr lesen zu:
Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Biosante Pharmaceuticals, Inc. for Securities Fraud | |
| 08.05.
| BioSante Pharmaceuticals Reports First Quarter Financial Results | | 40 | Business Wire |
| BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its
financial results for the first quarter of 2012 and cash balance as of
March 31, 2012.
...
Mehr lesen zu:
BioSante Pharmaceuticals Reports First Quarter Financial Results | |
| 03.05.
| Small Biotech Companies Look to Benefit From Shift to "First to File" Patent System / The Paragon Report Provides Stock Research on Biosante Pharmaceuticals and Advanced Cell Technology | | 32 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/03/12 -- Biotech stocks have continued to provide investors with strong gains in 2012. The iShares NASDAQ Biotechnology Index (IBB) is up nearly 20 percent year-to-date....
Mehr lesen zu:
Small Biotech Companies Look to Benefit From Shift to "First to File" Patent System / The Paragon Report Provides Stock Research on Biosante Pharmaceuticals and Advanced Cell Technology | |
| 23.04.
| Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents / The Paragon Report Provides Stock Research on Biosante Pharmaceuticals Inc. and Exelixis, Inc. | | 72 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 04/23/12 -- Mergers and Acquisitions have been a hot topic in in the Biotechnology Industry recently. Pharmaceutical giants face an unprecedented number of patent expirations...
Mehr lesen zu:
Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents / The Paragon Report Provides Stock Research on Biosante Pharmaceuticals Inc. and Exelixis, Inc. | |
| 11.04.
| Possible Bullish Inside Day Candle Pattern Detected for Biosante Pharmaceuticals | | 28 | SmarTrend |
| 10.04.
| Relatively High Enterprise Value to Sales Ratio Detected in Shares of Biosante Pharmaceuticals in the Biotechnology Industry | | 30 | SmarTrend |
| 04.04.
| Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | | 73 | PR Newswire |
| NEW YORK, April 4, 2012 /PRNewswire/ --Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf...
Mehr lesen zu:
Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | |
| 04.04.
| INVESTOR ALERT: Approximately 48 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc. | | 56 | MarketWire |
| NEW ORLEANS, LA -- (Marketwire) -- 04/04/12 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only...
Mehr lesen zu:
INVESTOR ALERT: Approximately 48 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc. | |
| 03.04.
| Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | | 57 | Business Wire |
| Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the Northern District
of Illinois on behalf of investors...
Mehr lesen zu:
Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position | |
| 29.03.
| BioSante Pharmaceuticals Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Possible Breaches of Fiduciary Duty by the Officers and Directors of BioSante Pharmaceuticals, Inc. | | 95 | Business Wire |
| Former United States Securities and Exchange Commission attorney Willie
Briscoe, founder of The
Briscoe Law Firm, PLLC, and the securities litigation firm of Powers
...
Mehr lesen zu:
BioSante Pharmaceuticals Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Possible Breaches of Fiduciary Duty by the Officers and Directors of BioSante Pharmaceuticals, Inc. | |
| 20.03.
| BioSante Announces Positive Pill-Plus Data Presentation | | 106 | AFX News |
| WASHINGTON (dpa-AFX) - BioSante Pharmaceuticals, Inc. (BPAX) announced that
data from studies of the Pill-Plus 'triple component' oral contraceptive were
presented on March 10, 2012 by Pantarhei...
Mehr lesen zu:
BioSante Announces Positive Pill-Plus Data Presentation | |
| 20.03.
| BioSante (BPAX) Reports Encouraging Data from Recent Pill-Plus Studies | | 4 | StreetInsider.com |
| 20.03.
| BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation | | 62 | Business Wire |
| Improvements reported in sexual desire, arousal, responsiveness and
activity
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that data...
Mehr lesen zu:
BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation | |
| 19.03.
| FAST Act to Modernize Approval Process -- Cardium and BioSante Poised to Benefit / The Paragon Report Provides Equity Research on Cardium Therapeutics & BioSante Pharmaceuticals | | 58 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 03/19/12 -- Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation out of Washington boosts the sector's reach....
Mehr lesen zu:
FAST Act to Modernize Approval Process -- Cardium and BioSante Poised to Benefit / The Paragon Report Provides Equity Research on Cardium Therapeutics & BioSante Pharmaceuticals | |
| 13.03.
| BioSante Pharmaceuticals Reports Financial Results for 2011 and Corporate Highlights | | 90 | Business Wire |
| BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced financial
results for the year ended December 31, 2011 and additional corporate
highlights.
...
Mehr lesen zu:
BioSante Pharmaceuticals Reports Financial Results for 2011 and Corporate Highlights | |
| 13.03.
| BioSante Pharmaceuticals, Inc. (BPAX) Investor Lawsuit and Deadline on April 6 Announced by Shareholders Foundation | | 64 | MarketWire |
| SAN DIEGO, CA -- (Marketwire) -- 03/13/12 -- The Shareholders Foundation, Inc. announces that a lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of...
Mehr lesen zu:
BioSante Pharmaceuticals, Inc. (BPAX) Investor Lawsuit and Deadline on April 6 Announced by Shareholders Foundation | |
